PHARMPROTECH HOLDING ApS: Financial statements 2022
CVR: 29174644
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
PHARMPROTECH HOLDING ApS (CVR 29174644) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -10,000 and a net result of DKK 5,580,991 compared with DKK 1,278,149 the year before. Equity in the 2022 report amounted to DKK 23,589,427. The solvency ratio was 85.4%.
- Gross Profit
- DKK -10,000
- Profit/Loss
- DKK 5,580,991
- Equity
- DKK 23,589,427
- Total Assets
- DKK 27,631,945
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -10 t. | 5.6 mio. | 23.6 mio. | - |
| 2021 | - | -10 t. | 1.3 mio. | 18.1 mio. | - |
| 2020 | - | -6 t. | 5.4 mio. | 16.8 mio. | - |
| 2019 | - | -44 t. | 1.9 mio. | 11.6 mio. | - |
| 2018 | - | 212 t. | 2 mio. | 9.7 mio. | - |
Official annual report
Keep an eye on PHARMPROTECH HOLDING ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMPROTECH HOLDING ApS has published its annual report for 2021. Gross profit came to DKK -10,000, and the net result was DKK 1,278,149.
About PHARMPROTECH HOLDING ApS
PHARMPROTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2005. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tony Christensen. The company is owned by Tony Christensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity in the 2025 report amounted to DKK 38,132,221.